More on ERAS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.7 Score)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Erasca, Inc (NQ:ERAS)
Delayed: 16.76 --0 (-0%)
Prev. Close $16.76  
Open$16.76 
52 Wk High$ 
52 Wk Low$ 
Day High$16.76 
Day Low$16.76 
P/E N/A  
EPS$ 
Volume107 

Friends, Peers and Foes (?): PODD, PSIX, RVMD, HUBG, NEHC (more...)

Aug 27, 2026 08:30 AM Erasca Inc (ERAS) PT Raised to $33 at JPMorgan
Aug 26, 2026 08:03 AM Important Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); New Era Energy & Digital, Inc. (NASDAQ: NUAI) (formerly known as New Era Helium (NASDAQ:
Aug 24, 2026 08:15 AM Form 8-K Erasca, Inc. For: Aug 24
Aug 24, 2026 08:01 AM FDA grants fast track status to Erasca's ERAS-0015 for pancreatic cancer
Aug 24, 2026 08:00 AM Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic Adenocarcinoma
Aug 17, 2026 02:14 PM Form 144 Erasca, Inc. Filed by: Erasca Foundation
Aug 17, 2026 07:07 AM Erasca (ERAS) Reiterated at Buy by Stifel After Annual Stifel Summer Biotech Summit
Aug 14, 2026 04:35 PM Form SCHEDULE 13G/A Erasca, Inc. Filed by: City Hill, LLC
Aug 14, 2026 09:04 AM Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Offic
Aug 14, 2026 05:18 AM Erasca Inc (ERAS) PT Raised to $20 at BofA Securities
View All Articles

Entities mentioned with eras

View All Entities